We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Amalgam Rx Stock

Invest in or calculate the value of your shares in Amalgam Rx or other pre-IPO companies through EquityZen's platform.

Get Started

Amalgam Rx Stock (AMRX)

Amalgam Rx is a digital health company that combines clinical and behavioral interventions to support patients, providers, & life sciences.

About Amalgam Rx Stock

Founded

2016

Headquarters

Wilmington, DE, US

Industries

Software, Data and Analytics, Artificial Intelligence

Amalgam Rx is the leader in bringing providers, life sciences, and digital solutions together. For more than 15 years, our team has been reimagining care delivery and creating lasting change across the chronic care ecosystem. Working in partnership with many of the world’s leading life sciences companies, Amalgam Rx has built an innovative platform for rapidly developing and scaling digital solutions — delivered through a wide variety of business models. Our proven end-to-end methodology enables the entire life cycle from R&D to commercialization. Amalgam’s solutions have generated more than 5 billion RWE data points utilized by patients and providers on three continents. For more information on how Amalgam Rx’s regulated, clinically validated technologies bring patients and providers closer together, reduce costs for payers, and unlock sustained value for partners, visit amalgamrx.com.

Amalgam Rx Press Mentions

Stay in the know about the latest news on Amalgam Rx

Amalgam Rx Management

Leadership team at Amalgam Rx

CMO

Suzanne Sysko Clough

CEO

Ryan Sysko

Locked Features

Join now and verify your accreditation status to gain access to:

  • Amalgam Rx current valuation
  • Amalgam Rx stock price
  • Available deals in Amalgam Rx and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Amalgam Rx stock?

Accredited investors can buy pre-IPO stock in companies like Amalgam Rx through EquityZen funds. These investments are made available by existing Amalgam Rx shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Amalgam Rx stock?

Shareholders can sell their Amalgam Rx stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."